Integrative proteo-genomic profiling uncovers key biomarkers of lapatinib resistance in HER2-positive breast cancer

ABSTRACT: To understand the transcriptomic, genomic and proteomics changes between HER2 overexpressingcells and those that have become resistant to lapatinib

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Breast

DISEASE(S): Breast Cancer

SUBMITTER: Vinothini Rajeeve  

LAB HEAD: Professor Pedro Cutillas

PROVIDER: PXD056848 | Pride | 2025-11-17

REPOSITORIES: Pride